NYSEArca - Nasdaq Real Time Price USD

Fidelity MSCI Health Care Index ETF (FHLC)

72.09 -0.19 (-0.27%)
As of 9:34 AM EDT. Market Open.
Loading Chart for FHLC
DELL
  • Previous Close 72.28
  • Open 71.74
  • Bid 70.00 x 900
  • Ask 73.34 x 900
  • Day's Range 72.09 - 72.09
  • 52 Week Range 57.32 - 74.48
  • Volume 2,474
  • Avg. Volume 133,872
  • Net Assets 2.99B
  • NAV 71.63
  • PE Ratio (TTM) 26.07
  • Yield 1.31%
  • YTD Daily Total Return 11.84%
  • Beta (5Y Monthly) 0.71
  • Expense Ratio (net) 0.08%

The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care 25/50 Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care 25/50 Index. The fund is non-diversified.

Fidelity Investments

Fund Family

Health

Fund Category

2.99B

Net Assets

2013-10-21

Inception Date

Performance Overview: FHLC

View More

Trailing returns as of 10/8/2024. Category is Health.

YTD Return

FHLC
11.84%
Category
10.57%
 

1-Year Return

FHLC
19.06%
Category
21.36%
 

3-Year Return

FHLC
5.55%
Category
0.43%
 

People Also Watch

Holdings: FHLC

View More

Top 10 Holdings (49.80% of Total Assets)

SymbolCompany% Assets
LLY
Eli Lilly and Company 10.96%
UNH
UnitedHealth Group Incorporated 8.28%
JNJ
Johnson & Johnson 6.00%
ABBV
AbbVie Inc. 5.32%
MRK
Merck & Co., Inc. 4.45%
TMO
Thermo Fisher Scientific Inc. 3.63%
ABT
Abbott Laboratories 3.02%
DHR
Danaher Corporation 2.84%
AMGN
Amgen Inc. 2.68%
ISRG
Intuitive Surgical, Inc. 2.63%

Sector Weightings

SectorFHLC
Healthcare   99.86%
Industrials   0.04%
Technology   0.01%
Real Estate   0.00%
Utilities   0.00%
Energy   0.00%

Recent News: FHLC

View More

Research Reports: FHLC

View More
  • Argus Quick Note: Weekly Stock List for 08/26/2024: Inside the Minds of the Big Guns

    Vickers Stock Research, a subsidiary of Argus Research Group, analyzes insider trading and institutional stock ownership. Form 13Fs, which institutions must file to report their holdings, are due 45 days after the end of calendar quarters and have come in for 2Q24. We review 13Fs of major institutional investors, including activists, to see what they are buying and to look for trends. Activist investing is now less about generating a short-term return and more about achieving long-term returns through an active management/investor partnership. The stock-market volatility during 2Q gave those institutional investors a chance to buy a dip. Taking a look at the 13Fs from well-known institutional portfolios, we see that the big guns were busy, either adding new holdings or increasing existing holdings. Buying was across a variety of sectors. Based on Vickers data, the following are select purchases made in 2Q by some high-profile money managers. We also list one significant sale (of Apple by Berkshire) and also note if the holding is now 4% or more of the total portfolio.

     
  • Bronfman makes an offer

    Paramount is a worldwide media entertainment company. Remerged in December 2019 from sister companies Viacom and CBS, the company produces and distributes television and cable programming over its networks, including the flagship CBS broadcast network; a stable of basic cable channels, including MTV Networks, VH1, Nickelodeon, Country Music Television, Comedy Central and BET; a network of owned and affiliated local CBS broadcast television stations; and various digital streaming video platforms, including its flagship Paramount+ service and Pluto TV. Paramount also produces and distributes theatrical films through its Paramount Pictures studio and owns a minority 12.5% share in the CW network. The company's businesses and trademarks also include the CBS television network, the Showtime cable network, CBS Television Distribution, and Paramount Pictures. ViacomCBS changed its name to Paramount Global on February 15, 2022.

    Rating
    Price Target
     
  • Every Cloud Has a Silver Lining; We Recommend Investors Buy Shares of ASML and Besi

    ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML’s main clients are TSMC, Samsung, and Intel.

    Rating
    Price Target
     
  • ASML Holding: Heathy Orders Calm Investor Concerns and Attention Shifts to China: Valuation Intact

    ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML’s main clients are TSMC, Samsung, and Intel.

    Rating
    Price Target
     

Related Tickers